Literature DB >> 30120966

SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns.

Aanchal Kakkar1, Vijay Mariadas Antony1, Raja Pramanik2, Pirabu Sakthivel3, Chirom Amit Singh3, Deepali Jain4.   

Abstract

A significant proportion of sinonasal malignancies comprise poorly differentiated/undifferentiated carcinomas that defy accurate histologic classification and behave aggressively. Recent years have seen a refinement of this spectrum by inclusion of novel entities harboring specific genetic alterations, including SMARCB1 (INI1)-deficient sinonasal carcinoma (SDSC), characterized by inactivating alterations in SMARCB1 gene, as demonstrated by loss of INI1 immunoexpression. Cyclin D1 is a cell-cycle regulatory protein downstream of INI1. Loss of INI1 leads to derepression of cyclin D1 transcription, suggesting its role as a putative therapeutic target. However, cyclin D1 expression has not been assessed in SDSCs. We retrieved all sinonasal carcinomas, including sinonasal undifferentiated carcinoma, undifferentiated carcinoma, poorly differentiated squamous cell carcinoma, and adenocarcinoma. Histopathologic features were reviewed. INI1 immunohistochemistry was performed. Cyclin D1 was performed in cases showing INI1 loss. Loss of INI1 staining was seen in 13 cases (5.8%), including 11 males and 2 females (age range, 11-65 years). Original diagnoses included SDSC (3/13), sinonasal undifferentiated carcinoma (3/13), adenocarcinoma (3/13), poorly differentiated squamous cell carcinoma (2/13), and poorly differentiated carcinoma (2/13). Tumors were predominantly basaloid in 6 cases and plasmacytoid/rhabdoid in 5 cases. We identified 2 cases having oncocytoid cells arranged in a gland-like pattern. Significant cyclin D1 immunoexpression was absent. SDSC is a rare, emerging entity that resembles a poorly differentiated carcinoma. Histomorphologic spectrum of these tumors is evolving. In addition to basaloid and plasmacytoid/rhabdoid cells, oncocytoid/adenocarcinoma-like pattern can also be seen in SDSC and predicts INI1 loss. These histologic patterns can further be subjected to INI1 immunohistochemistry for correct diagnosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basaloid; Oncocytic; Plasmacytoid; Rhabdoid; SMARCB1/ INI1; Sinonasal carcinoma

Mesh:

Substances:

Year:  2018        PMID: 30120966     DOI: 10.1016/j.humpath.2018.08.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change.

Authors:  Sho Tsuyama; Tsuyoshi Saito; Yoichi Akazawa; Yuka Yanai; Noboru Yatagai; Keisuke Akaike; Takuo Hayashi; Yoshiyuki Suehara; Fumiyuki Takahashi; Kazuya Takamochi; Takashi Hashimoto; Yoshiaki Kajiyama; Masahiko Tsurumaru; Tetsu Fukunaga; Takashi Yao
Journal:  Virchows Arch       Date:  2019-08-23       Impact factor: 4.064

2.  Diffuse spinal cord metastasis after resection of SMARCB1 sinonasal carcinoma manifesting with a right foot drop-a case report.

Authors:  Matheus Alves da Silva; Rafael Gemaque Lima Bentes; Hennan Salzedas Teixeira; Barbara Maini Carvalho; André Luiz Guimarães Queiroz; Marcelo Freitas Schmid; Karlla Danielle Ferreira Lima; William Souza Martins Ferreira; Christiane Monteiro de Siqueira Campos; Mateus Reghin Neto; Alex Machado Baeta
Journal:  Spinal Cord Ser Cases       Date:  2022-07-01

Review 3.  Sinonasal SMARCB1 (INI1) Deficient Carcinoma with Yolk Sac Tumor Differentiation: A Case Report and Treatment Options.

Authors:  Burak Hazir; Berkay Şímșek; Arzu Erdemír; Fatih Gürler; Ozan Yazici; Yusuf Kizil; Utku Aydíl
Journal:  Head Neck Pathol       Date:  2021-08-21

Review 4.  SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes.

Authors:  Victor Ho-Fun Lee; Raymond King-Yin Tsang; Anthony Wing Ip Lo; Sum-Yin Chan; Joseph Chun-Kit Chung; Chi-Chung Tong; To-Wai Leung; Dora Lai-Wan Kwong
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

5.  Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients.

Authors:  Marco Ferrari; Davide Mattavelli; Alberto Schreiber; Tommaso Gualtieri; Vittorio Rampinelli; Michele Tomasoni; Stefano Taboni; Laura Ardighieri; Simonetta Battocchio; Anna Bozzola; Marco Ravanelli; Roberto Maroldi; Cesare Piazza; Paolo Bossi; Alberto Deganello; Piero Nicolai
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

6.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.

Authors:  Abbas Agaimy
Journal:  Head Neck Pathol       Date:  2022-03-21

7.  Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.

Authors:  Snjezana Dogan; Paolo Cotzia; Ryan N Ptashkin; Gouri J Nanjangud; Bin Xu; Amir Momeni Boroujeni; Marc A Cohen; David G Pfister; Manju L Prasad; Cristina R Antonescu; Yingbei Chen; Mrinal M Gounder
Journal:  Hum Pathol       Date:  2020-08-18       Impact factor: 3.466

8.  SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.

Authors:  Horacio Gomez-Acevedo; John D Patterson; Sehrish Sardar; Murat Gokden; Bhaskar C Das; David W Ussery; Analiz Rodriguez
Journal:  BMC Cancer       Date:  2019-08-22       Impact factor: 4.430

Review 9.  SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.

Authors:  Pavithra Ayyanar; Pritinanda Mishra; Chappity Preetam; Amit Kumar Adhya
Journal:  Head Neck Pathol       Date:  2020-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.